Table 2.
Clinical Assessment | Baseline (n) | Post-Neoadjuvant (n) |
---|---|---|
Physical Examination (PE) | 43 | 44 |
Mammography (MG) | 30 | 29 |
Magnetic Resonance Imaging (MRI) | 33 | 34 |
Combination of modalities (PE, MG, and MRI) | 21 | 23* |
Note: n = number of patients;
= this number also includes pathological measurement in addition to the clinical modalities